With the global over 60-year-old population predicted to more than double over the next 35
years, caring for this aging population has become a major global healthcare challenge. In …

Background Antibiotics are frequently prescribed for acute exacerbations of COPD
(AECOPD) even though most do not have a bacterial aetiology. Biomarkers may help …

Challenges in the differentiation of the aetiology of acute exacerbations of chronic
obstructive pulmonary disease (AECOPD) have led to significant overuse of antibiotics …

Biomarkers to guide antibiotic treatment decisions have been proposed as an effective way
to enhancing a more appropriate use of antibiotics. As a biomarker, procalcitonin (PCT) has …

Background Early diagnosis and treatment of patients with sepsis reduce mortality
significantly. In terms of exploring new diagnostic tools of sepsis, monocyte distribution width …

Exacerbations of chronic obstructive pulmonary disease (COPD) are clinically relevant
events with therapeutic and prognostic implications. Yet, they are heterogeneous and can …

Chronic obstructive pulmonary disease (COPD) has significant contributions to morbidity
and mortality world-wide. Early symptoms of COPD are not readily distinguishable, resulting …

Introduction Chronic obstructive pulmonary disease (COPD) is strongly associated with the
development of community-acquired pneumonia (CAP). Limited data are available on risk …

Abstract Chronic Obstructive Pulmonary Disease (COPD) is a serious pulmonary condition.
Many patients experience exacerbations and some require Emergency Room visits and …

Exacerbations of chronic obstructive pulmonary disease (COPD) lead to high morbidity and
mortality. Respiratory virus infection is considered as one of the important causes of COPD …